SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant momentum and volatility as investors react to positive FDA briefing documents regarding its mRNA flu vaccine candidate ahead of a key advisory committee vote. The community is actively debating the stock's long-term growth potential through its expanding oncology and rare disease pipeline, while also tracking high short interest that has fueled speculation of a potential short squeeze.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is currently a focal point for investors debating the stock's future amid intense technical volatility and mixed signals regarding its long-term growth versus aggressive share dilution. While some community members highlight its expanding backlog, acquisition strategy, and defense sector partnerships, others are concerned by repeated price pullbacks and are closely monitoring the company's ability to capitalize on its recent strategic positioning.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is currently trending as investors debate the impact of its manufacturing joint venture with Toyota, with the community split between those viewing the partnership as a scaling moat and those concerned by ongoing stock volatility and dilution. Bulls emphasize the firm's progress in FAA flight testing and infrastructure development, while bears continue to highlight high cash burn and the speculative nature of the eVTOL industry.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is trending due to significant institutional accumulation and the building momentum surrounding the Agility Robotics commercialization narrative. Community sentiment remains focused on the potential for a major re-rating as investors compare the firm's strategic industrial partnerships to successful past robotics and infrastructure plays.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

Nuvation Bio is experiencing significant market volatility surrounding its earnings report as investors weigh the company's Ibtrozi commercial launch against concerns over patient retention in late-line treatments. Community sentiment remains split between long-term optimism regarding a potential buyout catalyst and frustration over recent downward price pressure and insider trading activity.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as investors monitor the commercial launch of NEREUS for motion sickness and engage in active speculation regarding potential buyout interest from major pharmaceutical players. While the community remains focused on the company's pipeline developments and GLP-1 adjunct opportunities, ongoing discussions are fueled by frustration over persistent price volatility and the company's aggressive regulatory strategy.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is experiencing significant volatility and heavy volume as traders debate the company's pivot toward becoming an AI infrastructure backbone through its Private Connectivity Fabric and recent strategic acquisitions. While bulls point to massive hyperscaler deal potential and a critical fiber footprint as long-term catalysts, the stock faces intense selling pressure from institutional shorting and concerns regarding balance sheet constraints and legacy business decline.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is currently trending as investors debate whether the recent double-digit share price slide represents a structural breakdown or a deep-value accumulation opportunity following an accelerated share buyback and cautious management guidance. Community sentiment is heavily polarized, with many retail investors expressing frustration over the persistent downtrend while active traders are aggressively positioning in LEAPs and accumulating common equity, betting on a technical bounce driven by the firm's core medical technology fundamentals.

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing intense selling pressure as investors grapple with shifting consumer spending, GLP-1 weight-loss drug impacts, and competition from other QSR brands. While the community remains divided between those viewing the pullback as a long-term accumulation opportunity for a defensive dividend payer and those concerned about weakening same-store sales and structural headwinds, the stock's recent volatility has triggered heavy speculation among short-term traders.

Riot Platforms, Inc. is a bitcoin mining company, which engages in the provision of special cryptocurrency mining computers. It invests in Verady, Coinsquare, and Tess. It operates through the Bitcoin Mining and Engineering segments. The Bitcoin Mining segment focuses on maximizing ability to successfully mine Bitcoin by growing hash rate. The Engineering segment designs and manufactures power distribution equipment and custom engineered electrical products that provides them the ability to vertically integrate many of the critical electrical components and engineering service. The company was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Riot Platforms Inc

Riot Platforms is seeing intense volatility as the community debates its pivot from Bitcoin mining to high-performance AI data center infrastructure. Investors are sharply divided, with some expressing frustration over recent price fluctuations and manipulative trading patterns, while others remain bullish on the long-term potential of the firm's power capacity and institutional partnerships.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PROSPERITY BANCSHARES, INC. COMPLETES MERGER WITH STELLAR BANCORP, INC.

PROSPERITY BANCSHARES, INC. COMPLETES MERGER WITH STELLAR BANCORP, INC. PROSPERITY BANCSHARES, INC. COMPLETES MERGER WITH STELLAR BANCORP, INC. PR Newswire HOUSTON, July 1, 2026 HOUSTON, July 1, 2026 /PRNewswire/ -- Prosperity Bancshares, Inc. ("Prosperity") (NYSE: PB), the parent company of...

Allison Transmission Holdings Set to Join S&P MidCap 400 and Goodyear Tire & Rubber to Join S&P SmallCap 600

Allison Transmission Holdings Set to Join S&P MidCap 400 and Goodyear Tire & Rubber to Join S&P SmallCap 600 Allison Transmission Holdings Set to Join S&P MidCap 400 and Goodyear Tire & Rubber to Join S&P SmallCap 600 PR Newswire NEW YORK, June 30, 2026 NEW YORK, June 30, 2026 /PRNewswire...

Why Prosperity Bancshares (PB) is a Great Dividend Stock Right Now

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Prosperity Bancshares (PB) have what it takes? Let's find out.

Huntington's Texas Deals to Drive Higher Profitability Through 2028

HBAN's Texas expansion is yielding early gains, with acquisitions expected to unlock $500M in synergies and boost profitability through 2028.

Prosperity Bancshares (PB) Down 0.5% Since Last Earnings Report: Can It Rebound?

Prosperity Bancshares (PB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Prosperity Bancshares (PB) Could Be a Great Choice

Vanguard Group Inc. Has $708.86 Million Stock Position in Prosperity Bancshares, Inc. $PB

Vanguard Group Inc. boosted its stake in shares of Prosperity Bancshares, Inc. (NYSE:PB - Free Report) by 1.4% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 10,256,927 shares of the bank's stock after buying an additional 140,035 shares during the peri...

Prosperity Bancshares Q1 Earnings Call Highlights

Prosperity Bancshares (NYSE:PB) reported higher full-year and fourth-quarter earnings for 2025, pointing to an improving net interest margin, stable expenses, and continued capital return through share repurchases. Management also used the call to highlight a series of bank transactions, including t...

Vest Financial LLC Makes New Investment in Prosperity Bancshares, Inc. $PB

Vest Financial LLC bought a new position in shares of Prosperity Bancshares, Inc. (NYSE:PB - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The...

Ned Holmes Sells 600 Shares of Prosperity Bancshares (NYSE:PB) Stock

Prosperity Bancshares, Inc. (NYSE:PB - Get Free Report) Director Ned Holmes sold 600 shares of Prosperity Bancshares stock in a transaction on Wednesday, April 29th. The shares were sold at an...

Prosperity Bancshares, Inc. is a holding company, which engages in the provision of financial products and solutions. It offers retail and commercial banking services such as deposits, online Internet banking, loan, investments, trust, and credit card to small and medium-sized businesses and consumers. The company was founded by Tracy T. Rudolph in 1983 and is headquartered in Houston, TX.

Prosperity Bancshares Inc.

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$1.49	--	--	N/A
Q1 '26	$1.31	$1.16	-11.64%	MISSED
Q4 '25	$1.42	$1.49	4.68%	BEAT
Q3 '25	$1.44	$1.45	0.72%	BEAT
Q2 '25	$1.41	$1.42	0.60%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

PBProsperity Bancshares Inc.

Upcoming Earnings: Q2 '26

Historical Earnings

Latest PB News